PubMed

Chromosomal aberrations in lymphocytes of healthy subjects and risk of cancer.

Rossner P, Boffetta P, Ceppi M, Bonassi S, Smerhovsky Z, Landa K, Juzova D, Srám RJ.

Environ Health Perspect. 2005 May;113(5):517-20.PMID: 15866756 [PubMed - indexed for MEDLINE]Related articlesFree article

Chromosomal aberration frequency in lymphocytes predicts the risk of cancer: results from a pooled cohort study of 22 358 subjects in 11 countries.

Bonassi S, Norppa H, Ceppi M, Strömberg U, Vermeulen R, Znaor A, Cebulska-Wasilewska A, Fabianova E, Fucic A, Gundy S, Hansteen IL, Knudsen LE, Lazutka J, Rossner P, Sram RJ, Boffetta P.

Carcinogenesis. 2008 Jun;29(6):1178-83. Epub 2008 Mar 19.PMID: 18356148 [PubMed - indexed for MEDLINE]Related articlesFree article

Chromosomal aberrations in lymphocytes predict human cancer: a report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH).

Hagmar L, Bonassi S, Strömberg U, Brøgger A, Knudsen LE, Norppa H, Reuterwall C.

Cancer Res. 1998 Sep 15;58(18):4117-21.PMID: 9751622 [PubMed - indexed for MEDLINE]Related articlesFree article

Chromosomal aberrations and cancer risk: results of a cohort study from Central Europe.

Boffetta P, van der Hel O, Norppa H, Fabianova E, Fucic A, Gundy S, Lazutka J, Cebulska-Wasilewska A, Puskailerova D, Znaor A, Kelecsenyi Z, Kurtinaitis J, Rachtan J, Forni A, Vermeulen R, Bonassi S.

Am J Epidemiol. 2007 Jan 1;165(1):36-43. Epub 2006 Oct 27.PMID: 17071846 [PubMed - indexed for MEDLINE]Related articlesFree article

[Biomarkers of cytogenetic damage in humans and risk of cancer. The European Study Group on Cytogenetic Biomarkers and Health (ESCH)]

Lando C, Hagmar L, Bonassi S.

Med Lav. 1998 Mar-Apr;89(2):124-31. Italian. PMID: 9673102 [PubMed - indexed for MEDLINE]Related articles

Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. European Study Group on Cytogenetic Biomarkers and Health.

Bonassi S, Hagmar L, Strömberg U, Montagud AH, Tinnerberg H, Forni A, Heikkilä P, Wanders S, Wilhardt P, Hansteen IL, Knudsen LE, Norppa H.

Cancer Res. 2000 Mar 15;60(6):1619-25.PMID: 10749131 [PubMed - indexed for MEDLINE]Related articlesFree article

Chromosome damage and cancer risk in the workplace: the example of cytogenetic surveillance in Croatia.

Fucić A, Znaor A, Strnad M, van der Hel O, Aleksandrov A, Miskov S, Grah J, Sedlar M, Jazbec AM, Ceppi M, Vermeulen R, Boffetta P, Norppa H, Bonassi S.

Toxicol Lett. 2007 Jul 30;172(1-2):4-11. Epub 2007 May 25.PMID: 17651925 [PubMed - indexed for MEDLINE]Related articles

Risk of cancer in an occupationally exposed cohort with increased level of chromosomal aberrations.

Smerhovsky Z, Landa K, Rössner P, Brabec M, Zudova Z, Hola N, Pokorna Z, Mareckova J, Hurychova D.

Environ Health Perspect. 2001 Jan;109(1):41-5.PMID: 11171523 [PubMed - indexed for MEDLINE]Related articlesFree article

Increased chromosome-type chromosome aberration frequencies as biomarkers of cancer risk in a blackfoot endemic area.

Liou SH, Lung JC, Chen YH, Yang T, Hsieh LL, Chen CJ, Wu TN.

Cancer Res. 1999 Apr 1;59(7):1481-4.PMID: 10197617 [PubMed - indexed for MEDLINE]Related articlesFree article

An inter-Nordic prospective study on cytogenetic endpoints and cancer risk. Nordic Study Group on the Health Risk of Chromosome Damage.

Brøgger A, Hagmar L, Hansteen IL, Heim S, Högstedt B, Knudsen L, Lambert B, Linnainmaa K, Mitelman F, Nordenson I, et al.

Cancer Genet Cytogenet. 1990 Mar;45(1):85-92.PMID: 2302690 [PubMed - indexed for MEDLINE]Related articles

Epidemiological evaluation of cytogenetic biomarkers as potential surrogate end-points for cancer.

Hagmar L, Strömberg U, Tinnerberg H, Mikoczy Z.

IARC Sci Publ. 2004;(157):207-15. Review.PMID: 15055297 [PubMed - indexed for MEDLINE]Related articles

Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage.

Hagmar L, Brøgger A, Hansteen IL, Heim S, Högstedt B, Knudsen L, Lambert B, Linnainmaa K, Mitelman F, Nordenson I, et al.

Cancer Res. 1994 Jun 1;54(11):2919-22.PMID: 8187078 [PubMed - indexed for MEDLINE]Related articlesFree article

Increased risk of cancer in radon-exposed miners with elevated frequency of chromosomal aberrations.

Smerhovsky Z, Landa K, Rössner P, Juzova D, Brabec M, Zudova Z, Hola N, Zarska H, Nevsimalova E.

Mutat Res. 2002 Feb 15;514(1-2):165-76.PMID: 11815255 [PubMed - indexed for MEDLINE]Related articles

Chromosomal aberrations and risk of cancer in humans: an epidemiologic perspective.

Bonassi S, Znaor A, Norppa H, Hagmar L.

Cytogenet Genome Res. 2004;104(1-4):376-82. Review.PMID: 15162068 [PubMed - indexed for MEDLINE]Related articles

Impact of types of lymphocyte chromosomal aberrations on human cancer risk: results from Nordic and Italian cohorts.

Hagmar L, Strömberg U, Bonassi S, Hansteen IL, Knudsen LE, Lindholm C, Norppa H.

Cancer Res. 2004 Mar 15;64(6):2258-63.PMID: 15026371 [PubMed - indexed for MEDLINE]Related articlesFree article

An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans.

Bonassi S, Znaor A, Ceppi M, Lando C, Chang WP, Holland N, Kirsch-Volders M, Zeiger E, Ban S, Barale R, Bigatti MP, Bolognesi C, Cebulska-Wasilewska A, Fabianova E, Fucic A, Hagmar L, Joksic G, Martelli A, Migliore L, Mirkova E, Scarfi MR, Zijno A, Norppa H, Fenech M.

Carcinogenesis. 2007 Mar;28(3):625-31. Epub 2006 Sep 14.PMID: 16973674 [PubMed - indexed for MEDLINE]Related articlesFree article

Chromosomal aberrations and SCEs as biomarkers of cancer risk.

Norppa H, Bonassi S, Hansteen IL, Hagmar L, Strömberg U, Rössner P, Boffetta P, Lindholm C, Gundy S, Lazutka J, Cebulska-Wasilewska A, Fabiánová E, Srám RJ, Knudsen LE, Barale R, Fucic A.

Mutat Res. 2006 Aug 30;600(1-2):37-45. Epub 2006 Jul 11. Review.PMID: 16814813 [PubMed - indexed for MEDLINE]Related articles

The usefulness of cytogenetic biomarkers as intermediate endpoints in carcinogenesis.

Hagmar L, Strömberg U, Tinnerberg H, Mikoczy Z.

Int J Hyg Environ Health. 2001 Oct;204(1):43-7. Review.PMID: 11725344 [PubMed - indexed for MEDLINE]Related articles

Cancer predictive value of cytogenetic markers used in occupational health surveillance programs: a report from an ongoing study by the European Study Group on Cytogenetic Biomarkers and Health.

Hagmar L, Bonassi S, Strömberg U, Mikoczy Z, Lando C, Hansteen IL, Montagud AH, Knudsen L, Norppa H, Reuterwall C, Tinnerberg H, Brogger A, Forni A, Högstedt B, Lambert B, Mitelman F, Nordenson I, Salomaa S, Skerfving S.

Mutat Res. 1998 Sep 20;405(2):171-8.PMID: 9748557 [PubMed - indexed for MEDLINE]Related articles

Increased chromosome aberration frequencies in the Bowen's patients compared to non-cancerous skin lesions individuals exposed to arsenic.

Ghosh P, Banerjee M, De Chaudhuri S, Das JK, Sarma N, Basu A, Giri AK.

Mutat Res. 2007 Aug 15;632(1-2):104-10. Epub 2007 May 18.PMID: 17600756 [PubMed - indexed for MEDLINE]Related articles